Temporal trends in chronic complications of diabetes by sex in community-based people with type 2 diabetes: the Fremantle Diabetes Study by Wendy A. Davis, Timothy M. E. Davis

Get full text

Prevalence and prognostic significance of cardiac autonomic neuropathy in community-based people with type 2 diabetes: the Fremantle Diabetes Study Phase II by Timothy M. E. Davis, Eva Tan, Wendy A. Davis

Get full text

Comparative mortality and its determinants in community-based people with type 1 diabetes: the Fremantle Diabetes Study Phase I by Timothy M E Davis, Wendy A Davis, Ruwani Rajapaksa

Get full text

Group-Based Trajectory Modelling of Changes in Mobility over Six Years in Type 2 Diabetes: The Fremantle Diabetes Study Phase II by David G. Bruce, Wendy A. Davis, Timothy M. E. Davis

Get full text

The relationship between carotid disease and retinopathy in diabetes: a systematic review by Jocelyn J. Drinkwater, Timothy M. E. Davis, Wendy A. Davis

Get full text

Temporal Trends in Mortality Associated with Comorbid Type 2 Diabetes and Schizophrenia: The Fremantle Diabetes Study by Wendy A. Davis, David G. Bruce, Sergio E. Starkstein, Timothy M. E. Davis

Get full text

The Relationship between Pulmonary Artery Pressure and Mortality in Type 2 Diabetes: A Fremantle Diabetes Study Phase II and National Echocardiographic Database of Australia Data L... by Nishant Nundlall, David Playford, Geoff Strange, Timothy M. E. Davis, Wendy A. Davis

Get full text

Prevalence, Incidence and Associates of Pulmonary Hypertension Complicating Type 2 Diabetes: Insights from the Fremantle Diabetes Study Phase 2 and National Echocardiographic Datab... by Nishant Nundlall, David Playford, Geoff Strange, Timothy M. E. Davis, Wendy A. Davis

Get full text

The relationship between hypomagnesemia, metformin therapy and cardiovascular disease complicating type 2 diabetes: the Fremantle Diabetes Study. by Kirsten E Peters, S A Paul Chubb, Wendy A Davis, Timothy M E Davis

Get full text

The Clinical Relevance of Diabetes Distress versus Major Depression in Type 2 Diabetes: A Latent Class Analysis from the Fremantle Diabetes Study Phase II by Wendy A. Davis, David G. Bruce, Timothy M. E. Davis, Sergio E. Starkstein

Get full text

Temporal Trends in Renal Replacement Therapy in Community-Based People with or without Type 2 Diabetes: The Fremantle Diabetes Study by Wendy A. Davis, Aron Chakera, Edward Gregg, Daniel McAullay, Timothy M. E. Davis

Get full text

Clinical impact of the temporal relationship between depression and type 2 diabetes: the Fremantle diabetes study phase II. by David G Bruce, Wendy A Davis, Violetta Cetrullo, Sergio E Starkstein, Timothy M E Davis

Get full text

The utility of the Diabetes Anxiety Depression Scale in Type 2 diabetes mellitus: The Fremantle Diabetes Study Phase II. by Wendy A Davis, David G Bruce, Milan Dragovic, Timothy M E Davis, Sergio E Starkstein

Get full text

Contemporary Cardiovascular Risk Assessment for Type 2 Diabetes Including Heart Failure as an Outcome: The Fremantle Diabetes Study Phase II by Wendy A. Davis, Valentina Hellbusch, Michael L. Hunter, David G. Bruce, Timothy M. E. Davis

Get full text

Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: the Fremantle Diabetes Study Phase II by Jocelyn J. Drinkwater, Timothy M. E. Davis, Valentina Hellbusch, Angus W. Turner, David G. Bruce, Wendy A. Davis

Get full text

Cost-effectiveness of artemisinin–naphthoquine versus artemether–lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children by Brioni R. Moore, Wendy A. Davis, Philip M. Clarke, Leanne J. Robinson, Moses Laman, Timothy M. E. Davis

Get full text

Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea by Wendy A Davis, Philip M Clarke, Peter M Siba, Harin A Karunajeewa, Carol Davy, Ivo Mueller, Timothy ME Davis

Get full text

Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes Study by Timothy M.E. Davis, Kirsten E. Peters, S. A. Paul Chubb, Leon A. Adams, Gary P. Jeffrey, Wendy A. Davis

Get full text

PromarkerD Predicts Renal Function Decline in Type 2 Diabetes in the Canagliflozin Cardiovascular Assessment Study (CANVAS) by Kirsten E. Peters, Jialin Xu, Scott D. Bringans, Wendy A. Davis, Timothy M.E. Davis, Michael K. Hansen, Richard J. Lipscombe

Get full text

Comprehensive mass spectrometry based biomarker discovery and validation platform as applied to diabetic kidney disease by Scott D. Bringans, Jun Ito, Thomas Stoll, Kaye Winfield, Michael Phillips, Kirsten Peters, Wendy A. Davis, Timothy M.E. Davis, Richard J. Lipscombe

Get full text